Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Zamicastat is an inhibitor of dopamine β-hydroxylase (DBH), and is also a concentration-dependent dual inhibitor of P-gp and BCRP(IC50 values of 73.8 μM and 17.0 μM, respectively).
Description | Zamicastat is an inhibitor of dopamine β-hydroxylase (DBH), and is also a concentration-dependent dual inhibitor of P-gp and BCRP(IC50 values of 73.8 μM and 17.0 μM, respectively). |
Targets&IC50 | Dopamine β-hydroxylase:, P-gp:73.8 μM , BCRP:17.0 μM |
In vivo | In the Dahl SS rat, Zamicastat (10, 30 and 100 mg/kg/day; oral bolus, 7 days) is tested acutely against salt-induced hypertension. Zamicastat produces a dose-dependent decrease in blood pressure[2]. |
Synonyms | BIA 5-1058 |
Molecular Weight | 401.47 |
Formula | C21H21F2N3OS |
CAS No. | 1080028-80-3 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 150 mg/mL (373.63 mM), Need ultrasonic
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Zamicastat 1080028-80-3 代谢 离子通道 神经科学 BCRP Hydroxylase P-gp ABCB1 Dopamine β-monooxygenase Inhibitor Cluster of differentiation 243 ABCG2 inhibit P-glycoprotein BIA 5-1058 Multidrug resistance protein 1 MDR1 CD243 Breast cancer resistance protein Pgp Dopamine β-hydroxylase Dopamine beta-hydroxylase Dopamine beta-monooxygenase inhibitor